Evidence for immune defects in breast and lung cancer patients
β Scribed by Iuliana Caras; A. Grigorescu; Crina Stavaru; D. L. Radu; I. Mogos; G. Szegli; Aurora Salageanu
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 232 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Levels of Clq binding activity have been measured in the sera of patients with benign and malignant breast disease. Cancer patients showed significantly higher binding activity than patients with gross fibrocystic disease. Clq binding levels were not related to levels of carcinoembryonic antigen, or
## Abstract The ability of a lung cancerβassociated antigen (LCAA) to provoke specific cutaneous delayedβhypersensitivity reactions has been studied on a group of 59 lung cancer patients. Biological activity of LCAA, monitored by skin testing, was demonstrated in 32% (17 of 53) of lung cancer patie